Delivery Order SPE2DB22D9353-SPE2DB23FX2JM
- Not listed
- The Defense Logistics Agency Troop Support Medical awarded a $19,518.56 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the supply of 4561836455 TYSABRI 300 MG/15 ML VIAL 15ML. The place of performance is Park Ridge, Illinois and the period of performance is August 11, 2023 through September 1, 2023. No major subcontractors or set aside designations were indicated. This delivery order was issued against an existing DLA medical supply vehicle to provide the multiple sclerosis...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $19,518 to DMS Pharmaceutical Group Inc. to supply TYSABRI 300 MG/15 ML VIAL 15ML. The place of performance is Park Ridge, Illinois. The period of performance is from August 10, 2023 through August 31, 2023. As the DLA supports the logistical needs of the Department of Defense, this delivery order is likely providing a pharmaceutical product in support of DOD medical treatment programs over the...
- The Defense Logistics Agency awarded a $19,518.56 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the procurement of TYSABRI 300 MG/15 ML VIAL 15ML pharmaceutical products. The prime contractor will deliver the products to the place of performance in Park Ridge, Illinois by September 11, 2023 in support of DLA programs. No subcontractors or set aside designations were identified. The delivery order was issued against an unspecified DLA-wide contract vehicle and will...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at fourteen thousand, six hundred thirty-eight dollars and ninety-two cents ($14,638.92) to DMS Pharmaceutical Group Inc. to supply Tysabri 300 MG/15 ML vials. Performance will take place in Park Ridge, Illinois under a contract scheduled from July 3, 2023 through July 25, 2023. The delivery order was placed against an unspecified agency-wide contract vehicle to procure the multiple sclerosis drug for distribution in...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at thirty-nine thousand thirty-seven dollars and twelve cents ($39,037.12) to DMS Pharmaceutical Group Inc. to supply TYSABRI 300 MG/15 ML VIAL 15ML pharmaceutical products. Performance will take place in Park Ridge, Illinois under a start date of July 18, 2023 and end date of August 8, 2023. The DLA facilitates the delivery of medical supplies and equipment to support Department of Defense programs. No...
- The Defense Logistics Agency Troop Support Medical awarded a $9,759 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for TYSABRI 300 MG/15 ML VIAL 15ML pharmaceutical products. The place of performance is Park Ridge, Illinois, and the period of performance is July 25, 2023 through August 15, 2023. The Defense Logistics Agency supports Department of Defense health care programs by procuring pharmaceuticals, medical supplies, and equipment for military treatment facilities...
- The Defense Logistics Agency Troop Support Medical awarded a $19,518.56 firm fixed price delivery order to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The order is for 4561565376 units of TYSABRI 300 MG/15 ML VIAL 15ML pharmaceutical products to be delivered between July 18, 2023 and August 8, 2023 to a location in Park Ridge. No major subcontractors or set aside designations were identified. The Defense Logistics Agency supports the medical readiness of the Armed Forces by...
- The Defense Logistics Agency Troop Support Medical awarded a $9,778 delivery order to DMS Pharmaceutical Group Inc. for TYSABRI 300 MG/15 ML VIAL 15ML pharmaceutical products. The firm fixed price order is being fulfilled under the prime contractor's performance from September 21, 2023 through October 13, 2023 at its facility located in Park Ridge, Illinois. No additional details were provided regarding the original solicitation or whether this delivery order was issued against an existing...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,262.76 to DMS Pharmaceutical Group Inc. on August 18, 2025, for the supply of TYSABRI 300 mg/15 ml vials. This firm fixed-price delivery order is scheduled for completion by September 9, 2025, with performance taking place at the vendor's facility in Park Ridge, Illinois. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis despite its status as a woman-owned...
- The Defense Logistics Agency awarded a $4,879 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply TYSABRI 300 MG/15 ML VIAL pharmaceutical products. The order is being fulfilled under an existing prime vendor contract vehicle and supports DLA's medical supply procurement programs. DMS will deliver the TYSABRI products to a customer located in Park Ridge, Illinois by July 28, 2023, fulfilling requirements originally requested through this agency. No subcontractors or set...
- SPE2DB22D9353Indefinite Delivery Contract
- SPE2DB22D9353-SPE2DB23FX2JMDelivery Order
The Defense Logistics Agency awarded a firm fixed price delivery order valued at fourteen thousand six hundred thirty-eight dollars and ninety-two cents ($14,638.92) to DMS Pharmaceutical Group Inc. to supply 4562100532 TYSABRI 300 MG/15 ML VIAL 15ML. The place of performance will be in Park Ridge, Illinois. The period of performance is from September 6, 2023 through September 27, 2023. No set aside designation or subcontractors were identified. The Defense Logistics Agency supports America's armed forces by delivering critical supplies such as pharmaceuticals and medical materiel. This delivery order enables the procurement of multiple vials of the drug TYSABRI, which is used to treat relapsing forms of multiple sclerosis and Crohn's disease.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.6k | 9/6/23 |